Rohit Jain

Roswell Park Comprehensive Cancer Center — United States

Medicine · Health Sciences

41h-index8.8kcitations287works5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(92), Cancer Immunotherapy and Biomarkers(56), Urinary and Genital Oncology Studies(45), Renal cell carcinoma treatment(29), Immunotherapy and Immune Responses(19)

Publications285 total

Navigating Autonomy: Enhancing Accuracy in Medical Decision-making Capacity Assessment
Annals of African Medicine·2025
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer
Cancer Chemotherapy and Pharmacology·2025· 1 citedOpen Access
Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-Preserving Trimodality Therapy
The Journal of Urology·2025· 1 cited
Pembrolizumab plus High-Dose IL-2 in Advanced Clear Cell Renal Cell Carcinoma: Six-Year Survival Outcomes and Molecular Signatures from a Phase 2 Trial
2025Open Access
Germline whole-exome sequencing reveals <i>FOXP3</i>-related gene variants conferring urinary cancer susceptibility and associated with immune escape
Journal for ImmunoTherapy of Cancer·2025Open Access
EXTENDED REALITY (XR) TECHNOLOGIES IN MENTAL HEALTH ASSESSMENT AND TREATMENT
International Journal of Advanced Research·2025Open Access
Fever in Myocardial Infarction-Related Cardiogenic Shock
JACC Advances·2025Open Access
The Nexus of Mouthwash, Oral Dysbiosis, and Cardiovascular Health: A Review
Eastern Journal of Medical Sciences·2025· 1 citedOpen Access
Current perspectives on pertussis outbreaks: Causes and consequences
Clinical Microbiology Newsletter·2025· 2 cited
Mast cells activated in vitro can modulate macrophage polarization and antibacterial responses
Journal of Allergy and Clinical Immunology·2025· 3 citedOpen Access
Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab Trial
European Urology Oncology·2025· 1 citedOpen Access
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer
2025· 1 citedOpen Access
THE IMPACT OF FEVER IN PATIENTS WITH CARDIOGENIC SHOCK AFTER ACUTE MI MANAGED WITH A PULMONARY ARTERY CATHETER
Journal of the American College of Cardiology·2025Open Access
THE IMPACT OF FEVER IN ACUTE MI PATIENTS RECEIVING MECHANICAL CIRCULATORY SUPPORT
Journal of the American College of Cardiology·2025Open Access
TRENDS IN THE USE OF ANTIBIOTICS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION RELATED CARDIOGENIC SHOCK
Journal of the American College of Cardiology·2025Open Access
A phase 2 trial of neoadjuvant futibatinib plus durvalumab for cisplatin-ineligible patients with <i>FGFR</i> overexpressing muscle-invasive bladder cancer.
Journal of Clinical Oncology·2025
ETCTN 10483: Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR3/2 genetic alterations (GAs).
Journal of Clinical Oncology·2025· 2 cited
Spatial transcriptomic analysis of tumor tissue from patients with metastatic urothelial carcinoma (mUC) receiving ipilimumab (IPI) plus nivolumab (Nivo) combined with sacituzumab govitecan (SG).
Journal of Clinical Oncology·2025
A Comprehensive Study Of Colorectal Adenocarcinoma And Its Correlation With COX‐2 And HER‐2/NEU IHC Markers
Research Journal of Medical Sciences·2024Open Access
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
Nature Medicine·2024· 24 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Wolfgang Weninger(15), Sunil Badve(10), Ben Roediger(7), Rutika Mehta(7), Lai Guan Ng(5), Jingsong Zhang(5), Shweta Tikoo(4), Harikrishna Nakshatri(4), Logan Zemp(4), Jad Chahoud(4), Philippe E. Spiess(4), Roger Li(4), Neeraj Agarwal(3), Petros Grivas(3), Andrew J. Mitchell(3), Philip L. Tong(3), Michele A. Grimbaldeston(3), Maté Biro(3), Chi Ching Goh(3), Lois L. Cavanagh(3)